MACULAR DEGENERATION
Clinical trials for MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene therapy trial for dry AMD shows early promise but study halted
Disease control TerminatedThis study tested a single injection of a gene therapy called GT005 in 56 people with dry age-related macular degeneration (AMD), a leading cause of vision loss. The goal was to see if it was safe and could slow or stop damage to the retina. The trial was stopped early, so result…
Matched conditions: MACULAR DEGENERATION
Phase: PHASE1, PHASE2 • Sponsor: Gyroscope Therapeutics Limited • Aim: Disease control
Last updated May 26, 2026 08:34 UTC
-
New eye scanner software aims to sharpen vision for doctors
Diagnosis TerminatedThis study tested a new software called AngioScan on an FDA-approved eye camera to see if it can take clearer pictures of the back of the eye. The goal was to help doctors better diagnose and treat conditions like macular degeneration and other retinal blood vessel problems. Abou…
Matched conditions: MACULAR DEGENERATION
Sponsor: University of California, Los Angeles • Aim: Diagnosis
Last updated May 20, 2026 11:55 UTC